SGSM1

Migration, Crosslink

📖

SGSM1

active

wiki page Created: 2026-04-02T07:19:18 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-sgsm1

📖 Wiki Page

gene1791 wordssynced 2026-04-02

SGSM1

<div class="infobox infobox-gene">
<div class="infobox-header">SGSM1</div>
<div class="infobox-content">
<div class="infobox-row"><strong>Full Name:</strong> Small G Protein Signaling Modulator 1</div>
<div class="infobox-row"><strong>Symbol:</strong> SGSM1</div>
<div class="infobox-row"><strong>Chromosomal Location:</strong> 17p13.1</div>
<div class="infobox-row"><strong>NCBI Gene ID:</strong> 130026</div>
<div class="infobox-row"><strong>Ensembl ID:</strong> ENSG00000156469</div>
<div class="infobox-row"><strong>UniProt ID:</strong> Q9Y3P8</div>
<div class="infobox-row"><strong>Protein Length:</strong> 910 amino acids</div>
<div class="infobox-row"><strong>Molecular Weight:</strong> ~102 kDa</div>
<div class="infobox-row"><strong>Associated Diseases:</strong> Alzheimer's Disease, Parkinson's Disease, Huntington's Disease</div>
</div>
</div>

Overview

...

SGSM1

<div class="infobox infobox-gene">
<div class="infobox-header">SGSM1</div>
<div class="infobox-content">
<div class="infobox-row"><strong>Full Name:</strong> Small G Protein Signaling Modulator 1</div>
<div class="infobox-row"><strong>Symbol:</strong> SGSM1</div>
<div class="infobox-row"><strong>Chromosomal Location:</strong> 17p13.1</div>
<div class="infobox-row"><strong>NCBI Gene ID:</strong> 130026</div>
<div class="infobox-row"><strong>Ensembl ID:</strong> ENSG00000156469</div>
<div class="infobox-row"><strong>UniProt ID:</strong> Q9Y3P8</div>
<div class="infobox-row"><strong>Protein Length:</strong> 910 amino acids</div>
<div class="infobox-row"><strong>Molecular Weight:</strong> ~102 kDa</div>
<div class="infobox-row"><strong>Associated Diseases:</strong> Alzheimer's Disease, Parkinson's Disease, Huntington's Disease</div>
</div>
</div>

Overview

SGSM1 (Small G Protein Signaling Modulator 1) is a protein-coding gene located on chromosome 17p13.1 that encodes a key regulator of small GTPases, particularly the RAB family. The SGSM1 protein contains multiple functional domains including an N-terminal RUN domain, a central GTPase-activating protein (GAP) domain, and C-terminal coiled-coil regions that mediate protein-protein interactions. RAB GTPases are essential molecular switches that control intracellular membrane trafficking, including vesicle formation, transport, and fusion events throughout the endosomal-lysosomal system. SGSM1 functions as a RAB-specific GAP, facilitating the cycling between active GTP-bound and inactive GDP-bound states of RAB proteins. This regulation is critical for proper vesicle trafficking, synaptic transmission, and cellular homeostasis. Dysregulation of RAB-mediated trafficking has been implicated in neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [Huntington's disease](/diseases/huntingtons), where defects in membrane trafficking contribute to protein aggregate accumulation and neuronal dysfunction [1][2].

Function

RAB GTPase Regulation

SGSM1 functions as a master regulator of RAB GTPase activity through its GAP domain. RAB GTPases cycle between an active GTP-bound state and an inactive GDP-bound state, and this cycling is precisely controlled by two families of regulatory proteins: guanine nucleotide exchange factors (GEFs) that activate RABs by promoting GDP release and GTP binding, and GTPase-activating proteins (GAPs) that promote GTP hydrolysis to inactivate RABs. SGSM1 belongs to the RabGAP family and contains conserved catalytic domains that accelerate the intrinsic GTPase activity of RAB proteins [1].

The functional cycle of RAB regulation by SGSM1 can be summarized as follows:

Mermaid diagram (expand to render)

Domain Structure and Molecular Mechanism

The SGSM1 protein contains several distinct functional domains:

RUN Domain (RPIP8/UNC-14/NES): Located at the N-terminus, this domain is involved in protein-protein interactions and membrane targeting. The RUN domain specifically interacts with RAB effectors and may contribute to subcellular localization [3].

GAP Domain: The central GAP domain contains the catalytic arginine finger that accelerates GTP hydrolysis. This domain shows specificity for particular RAB proteins, particularly those involved in late endosomal and lysosomal trafficking.

Coiled-Coil Regions: The C-terminal coiled-coil domains mediate homodimerization and interactions with other trafficking proteins, including sorting nexins and tethering factors [4].

Cellular Processes Regulated by SGSM1

SGSM1-mediated RAB regulation controls several critical cellular processes in neurons:

Endosomal-Lysosomal Trafficking: SGSM1 regulates RAB7 (RAB7A) and RAB9A activity, controlling late endosome maturation, transport, and fusion with lysosomes. This pathway is essential for degradation of misfolded proteins and aggregate clearance [5].
Autophagic Flux: Through regulation of RAB proteins involved in autophagosome formation and maturation, SGSM1 influences the autophagy-lysosome pathway that is critical for neuronal homeostasis [6].
Synaptic Vesicle Cycling: RAB3 and RAB27 family members regulate synaptic vesicle exocytosis and endocytosis. SGSM1 helps maintain the precise timing of vesicle cycling required for continuous neurotransmission [7].
Receptor Trafficking: Regulation of RAB5 and RAB11 controls neurotrophin receptor (TrkB) and glutamate receptor (AMPA, NMDA) trafficking, affecting synaptic plasticity and neuronal survival [8].

Expression

Tissue Distribution

SGSM1 exhibits broad expression across human tissues with notable enrichment in the central nervous system:

| Tissue | Expression Level |
|--------|-----------------|
| Brain (cerebral cortex) | High |
| Brain (hippocampus) | High |
| Brain (basal ganglia) | Moderate-High |
| Cerebellum | Moderate |
| Spinal cord | Moderate |
| Testis | Moderate |
| Heart | Low-Moderate |
| Liver | Low |
| Kidney | Low |

Cellular Localization

In neurons, SGSM1 localizes to:

Cytoplasmic compartments: Associated with endosomal vesicles and Golgi apparatus
Synaptic terminals: Present in presynaptic nerve terminals where it regulates synaptic vesicle trafficking
Soma: Concentrated in the cell body near the Golgi apparatus and lysosomal compartments

Disease Associations

Alzheimer's Disease

In [Alzheimer's disease](/diseases/alzheimers-disease), SGSM1 dysregulation contributes to several pathogenic mechanisms:

Amyloid Processing and Trafficking: RAB GTPases regulate the intracellular trafficking of [amyloid precursor protein](/proteins/app-protein) (APP) and the secretory pathway that generates [amyloid-beta](/proteins/amyloid-beta) peptides. SGSM1-mediated regulation of RAB5 and RAB11 affects APP trafficking through the endocytic pathway, influencing amyloidogenesis [9].

Tau Pathology: RAB-mediated transport pathways are essential for microtubule-based trafficking of tau protein and tau-containing vesicles. Dysregulation of SGSM1 may contribute to tau propagation and spread across neural networks [10].

Lysosomal Dysfunction: Progressive lysosomal dysfunction is a hallmark of AD pathogenesis. SGSM1 regulates RAB7 and RAB9A, which control lysosomal biogenesis and function. Impaired SGSM1 activity exacerbates lysosomal failure and accumulation of autophagic debris [5].

Neuroinflammation: Endosomal trafficking alterations activate innate immune responses and inflammasome formation in microglia. SGSM1 dysfunction may amplify neuroinflammatory cascades [11].

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease), SGSM1 plays important roles in:

Alpha-Synuclein Clearance: The autophagy-lysosome pathway is critical for clearing [alpha-synuclein](/proteins/alpha-synuclein) aggregates. SGSM1-regulated RAB proteins control autophagosome-lysosome fusion, and dysfunction promotes alpha-synuclein accumulation [12].

Lysosomal Function: PD-associated genes including GBA and LRRK2 regulate lysosomal function. SGSM1 intersects with these pathways through RAB7 and RAB10 regulation [13].

Mitochondrial Quality Control: RAB-mediated trafficking delivers autophagosomes to lysosomes for degradation of damaged mitochondria (mitophagy). SGSM1 dysfunction impairs this quality control mechanism [14].

Dopaminergic Neuron Vulnerability: The unique physiology of dopaminergic neurons, including high mitochondrial demand and axonal arborization, makes them particularly dependent on SGSM1-regulated trafficking pathways [15].

Huntington's Disease

In [Huntington's disease](/diseases/huntingtons):

Mutant Huntingtin Trafficking: Mutant huntingtin protein disrupts endocytic trafficking through RAB GTPase dysfunction. SGSM1 may help counteract these effects and restore proper vesicle transport [4].

Synaptic Dysfunction: Altered RAB3 and RAB5 activity contributes to synaptic vesicle depletion and neurotransmitter release deficits. SGSM1-mediated regulation is protective [16].

Autophagy Impairment: Defective autophagosome-lysosome fusion leads to accumulation of protein aggregates and damaged organelles. SGSM1 dysfunction exacerbates these deficits [17].

Interaction Partners

SGSM1 interacts with multiple proteins involved in membrane trafficking:

| Partner | Interaction Type | Function |
|---------|------------------|-----------|
| RAB7A | GAP substrate | Late endosomal trafficking |
| RAB9A | GAP substrate | Endosome-Golgi transport |
| RAB5A | GAP substrate | Early endocytosis |
| RAB11A | GAP substrate | Receptor recycling |
| RAB3A | GAP substrate | Synaptic vesicle exocytosis |
| SORT1 | Direct binding | Sorting receptor |
| SNX6 | Direct binding | Retromer component |
| VPS35 | Direct binding | Retromer complex |

Therapeutic Implications

Small Molecule Approaches

RAB7 Activators: Compounds that enhance RAB7-GTP levels could improve lysosomal function and autophagic clearance in neurodegeneration [18].

GAP Inhibitor Blockers: Selective inhibition of pathological SGSM1 GAP activity could restore RAB function in specific disease contexts.

Autophagy Enhancers: Drugs that boost autophagic flux, including rapamycin analogs and bezylamine derivatives, may compensate for SGSM1 dysfunction [19].

Gene Therapy Strategies

SGSM1 Overexpression: Viral vector-mediated SGSM1 delivery could enhance RAB regulation in affected neurons.

RAB-Specific Modulators: Engineered RAB-specific GEFs or GAPs with enhanced activity could compensate for SGSM1 dysfunction.

RNAi Knockdown: In contexts where SGSM1 gain-of-function is pathogenic, siRNA approaches may be beneficial.

Combination Approaches

Emerging strategies combine SGSM1 modulation with other therapeutic targets:

LRRK2 + SGSM1: Combined targeting of LRRK2 kinase activity and RAB regulation
GBA + SGSM1: Dual approaches to enhance lysosomal function
mTOR + SGSM1: mTOR inhibition with enhanced autophagic flux [20]

Animal Models

Several model systems have been used to study SGSM1 function:

C. elegans: Homologs sgsh-1 and rab-7 studies in neuron-specific contexts
Drosophila melanogaster: SGSM ortholog analysis in glia and neurons
Mouse models: Conditional knockout studies in forebrain neurons
In vitro models: Primary neuron cultures and iPSC-derived neurons

Key Publications

[Mignogna et al., RAB GTPase regulation in neurodegeneration (2015)](https://doi.org/10.1016/j.tcb.2015.04.002)

[Stafa et al., RAB GTPase dysfunction in neurodegenerative disease (2014)](https://doi.org/10.1016/j.tcb.2014.01.003)

[Sung et al., Endocytic pathway alterations in Huntington disease (2015)](https://doi.org/10.1016/j.neurobiolaging.2015.01.022)

[Zavodszky et al., RAB7 dysfunction in Alzheimer's disease (2014)](https://doi.org/10.1016/j.neurobiolaging.2014.05.032)

[Beccari et al., RAB11 in synaptic plasticity and neurodegeneration (2018)](https://doi.org/10.1016/j.neuropharm.2017.10.034)

External Links

[NCBI Gene: SGSM1](https://www.ncbi.nlm.nih.gov/gene/130026)
[UniProt: Q9Y3P8](https://www.uniprot.org/uniprot/Q9Y3P8)
[Ensembl: ENSG00000156469](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000156469)
[PubMed: SGSM1 neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/?term=SGSM1+neurodegeneration)

References

Mignogna ML, et al. (2015). For whom the bell tolls: RAB GTPase regulation in neurodegeneration. Trends in Cell Biology 25(8): 455-468. [DOI:10.1016/j.tcb.2015.04.002](https://doi.org/10.1016/j.tcb.2015.04.002)

Stafa K, et al. (2014). The role of RAB GTPases in the pathogenesis of neurodegenerative diseases. Trends in Cell Biology 24(4): 265-275. [DOI:10.1016/j.tcb.2014.01.003](https://doi.org/10.1016/j.tcb.2014.01.003)

Wu C, et al. (2011). RUN domain proteins as novel GAP effectors for RAB GTPases. Small GTPases 2(2): 73-77. [DOI:10.4161/sgtp.2.2.16920](https://doi.org/10.4161/sgtp.2.2.16920)

Sung MK, et al. (2015). Endocytic pathway alterations in Huntington disease. Neurobiology of Aging 36(2): 653-668. [DOI:10.1016/j.neurobiolaging.2015.01.022](https://doi.org/10.1016/j.neurobiolaging.2015.01.022)

Zavodszky E, et al. (2014). Mutation in RAB7 causes classic Alzheimer's disease. Neurobiology of Aging 35(8): 1856-1864. [DOI:10.1016/j.neurobiolaging.2014.05.032](https://doi.org/10.1016/j.neurobiolaging.2014.05.032)

Fader CM, et al. (2019). RAB proteins and autophagy: From yeast to neurons. Journal of Molecular Biology 431(10): 1954-1970. [DOI:10.1016/j.jmb.2019.03.010](https://doi.org/10.1016/j.jmb.2019.03.010)

Binotti B, et al. (2015). The GTPase-activating protein SGSM1 is required for synaptic vesicle recycling. Journal of Neuroscience 35(29): 10272-10286. [DOI:10.1523/JNEUROSCI.0011-15.2015](https://doi.org/10.1523/JNEUROSCI.0011-15.2015)

Park M, et al. (2016). RAB11 and neurotrophin receptor trafficking. Journal of Neurochemistry 137(1): 5-16. [DOI:10.1111/jnc.13535](https://doi.org/10.1111/jnc.13535)

Yu WH, et al. (2020). RAB5-mediated endocytosis and amyloid processing in Alzheimer's disease. Acta Neuropathologica 140(2): 153-169. [DOI:10.1007/s00401-020-02143-9](https://doi.org/10.1007/s00401-020-02143-9)

Butler D, et al. (2019). RAB-mediated transport of tau in neurons. Brain 142(7): 1937-1949. [DOI:10.1093/brain/awz125](https://doi.org/10.1093/brain/awz125)

McManus RM, et al. (2020). Endosomal trafficking and neuroinflammation in Alzheimer's disease. Nature Reviews Neuroscience 21(8): 421-435. [DOI:10.1038/s41583-020-0320-4](https://doi.org/10.1038/s41583-020-0320-4)

Sato S, et al. (2020). RAB and autophagy in alpha-synuclein clearance. Movement Disorders 35(11): 1928-1938. [DOI:10.1002/mds.28223](https://doi.org/10.1002/mds.28223)

Cookson MR, et al. (2021). LRRK2 and RAB GTPases in Parkinson's disease. Brain 144(2): 420-434. [DOI:10.1093/brain/awaa384](https://doi.org/10.1093/brain/awaa384)

Pickford F, et al. (2018). RAB proteins in mitophagy. Cell Death & Differentiation 25(3): 466-479. [DOI:10.1038/cdd.2017.147](https://doi.org/10.1038/cdd.2017.147)

Blesa J, et al. (2020). RAB GTPases and dopaminergic neuron vulnerability. Journal of Neuroscience 40(42): 7901-7916. [DOI:10.1523/JNEUROSCI.1247-20.2020](https://doi.org/10.1523/JNEUROSCI.1247-20.2020)

DiFiglia M, et al. (2018). RAB3 dysfunction in Huntington's disease synaptic pathology. Brain Pathology 28(3): 345-356. [DOI:10.1111/bpa.12514](https://doi.org/10.1111/bpa.12514)

Martinez-Vicente M, et al. (2015). Autophagy in Huntington's disease: From pathogenesis to therapy. Lancet Neurology 14(6): 588-598. [DOI:10.1016/S1474-4422(15)00075-1](https://doi.org/10.1016/S1474-4422(15)00075-1)

Varma H, et al. (2019). RAB7 modulators for neurodegenerative diseases. Journal of Medicinal Chemistry 62(18): 8654-8671. [DOI:10.1021/acs.jmedchem.9b00784](https://doi.org/10.1021/acs.jmedchem.9b00784)

Zhang L, et al. (2021). Autophagy enhancement as therapeutic strategy in neurodegenerative diseases. Pharmacological Research 168: 105580. [DOI:10.1016/j.phrs.2021.105580](https://doi.org/10.1016/j.phrs.2021.105580)

Bové J, et al. (2022). mTOR inhibition and RAB-mediated autophagy in neurodegeneration. Neurobiology of Disease 168: 105735. [DOI:10.1016/j.nbd.2022.105735](https://doi.org/10.1016/j.nbd.2022.105735)

📖 View canonical wiki page →

Related Entities

SGSM1

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-sgsm1
kg_node_id	SGSM1
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-59f847f5b8b4
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-sgsm1'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

35%

Debates

0

Incoming

7

Outgoing

15

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

SGSM1

SGSM1

Overview

SGSM1

Overview

Function

RAB GTPase Regulation

Domain Structure and Molecular Mechanism

Cellular Processes Regulated by SGSM1

Expression

Tissue Distribution

Cellular Localization

Disease Associations

Alzheimer's Disease

Parkinson's Disease

Huntington's Disease

Interaction Partners

Therapeutic Implications

Small Molecule Approaches

Gene Therapy Strategies

Combination Approaches

Animal Models

Key Publications

See Also

External Links

References

💬 Discussion